terbutaline has been researched along with Renal Insufficiency, Chronic in 1 studies
Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.
Renal Insufficiency, Chronic: Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)
| Excerpt | Relevance | Reference |
|---|---|---|
| " The purpose of this study is to determine the pharmacokinetic properties of terbutaline in patients with severe renal impairment as defined by a glomerular filtration rate (GFR) below 30 mL/min." | 2.78 | Pharmacokinetics of terbutaline in chronic kidney disease. ( Bastiansen, A; Eggert, S; Pedersen, E, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bastiansen, A | 1 |
| Eggert, S | 1 |
| Pedersen, E | 1 |
1 trial available for terbutaline and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Pharmacokinetics of terbutaline in chronic kidney disease.
Topics: Adrenergic beta-2 Receptor Agonists; Adult; Aged; Female; Humans; Male; Middle Aged; Renal Insuffici | 2013 |